Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts

Journal of Clinical Investigation

Volumn 101, Issue 2, 1998, Pages 398-405

  Ciubotariu, Rodica ^a   Liu, Zhuoru ^a   Colovai, Adriana I ^a   Ho, Eric ^a   Itescu, Sylviu ^b   Ravalli, Stefano ^b   Hardy, Mark A ^b   Cortesini, Raffaello ^c   Rose, Eric A ^b   Suciu Foca, Nicole ^a  

^a Department of Pathology ^*  (United States)

^b Department of Surgery ^*  (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Coronary artery vasculopathy; Indirect allorecognition; Intermolecular spreading; Intramolecular spreading; Reactivity to HLA DR allopeptides

Indexed keywords

ALLOANTIGEN; AZATHIOPRINE; CYCLOSPORIN; EPITOPE; HLA ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RECOMBINANT INTERLEUKIN 2; STEROID;

ADULT; ALLOGRAFT; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE;

EID: 0032518422     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1117     Document Type: Article

References (55)

1. Miller, L.W., T. Donahue, T. Wolford, and J. Drury. 1996. In The Transplantation and Replacement of Thoracic Organs. D.K. Cooper, L.W. Miller, and G.A. Patterson, editors. Kluwer Academic Publishers, Boston. 335-350.
2. Stinson, E.B., R. Payne, R.B. Griepp, and E. Dong, Jr. 1971. Correlation of histocompatibility matching with graft rejection and survival after cardiac transplantation in man. Lancet. 2:459-461.
3. Frist, W., P. Oyer, J. Baldwin, E.B. Stinson, and N.E. Shumway. 1987. HLA compatibility and cardiac transplant recipient survival. Ann. Thorac. Surg. 44:242-246.
4. Smith, J., M.L. Rose, A. Pomerance, M. Burke, and M.H. Yacoub. 1995. Reduction of cellular rejection and increase in long-term survival after heart transplantation, after HLA-DR matching. Lancet. 346:1318-1322.
5. Costanzo-Nordin, M. 1992. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J. Heart Lung Transplant. 11:S90-S103.
6. Suciu-Foca, N., E. Reed, C. Marboe, Y.-P. Xi, S.-Y. Kai, E. Ho, E. Rose, K. Reemtsma, and D.W. King. 1991. Role of anti-HLA antibodies in heart transplantation. Transplantation. 51:716-724.
7. Hess, M., A. Hastillo, T. Mohanakumar, J.J. Cowley, G. Vetrovac, S. Szentpetery, T.C. Wolfgang, and R.R. Lower. 1983. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B cell antibodies and hyperlipidemia. Circulation. 68:94-101.
8. Rose, E., P. Pepino, M. Barr, C. Smith, A. Ratner, E. Ho, and C. Berger. 1992. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J. Heart Lung Transplant. 11:S120-S123.
9. Rose, E., C. Smith, G. Petrossian, M.L. Barr, and K. Reemtsma. 1989. Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery. 106:203-208.
10. Fenoglio, J., E. Ho, F., Reed, E. Rose, C. Smith, K. Reemtsma, C. Marboe, and N. Suciu-Foca. 1989. Anti-HLA antibodies and heart allograft survival. Transplant. Proc. 21:807-809.
11. Petrossian, G., A.B. Nichols, C.C. Marboe, R. Sciacca, E.A. Rose, C.R. Smith, P.J. Cannon, K. Reemtsma, and E.R. Powers. 1989. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation. 80:122-125.
12. Hayry, P. 1996. Pathophysiology of chronic rejection. Transplant. Proc. 28:7-10.
13. Hayry, P., S. Mennander, J. Yilmarz, J. Ustinov, A. Raisanen, A. Miettinen, I. Lautenschlager, K. Lemstrom, C.A. Bruggerman, and T. Paavonen. 1992. Towards understanding the pathophysiology of chronic rejection. Clin. Invest. 70:780-790.
14. Demetris, A.J., T. Zerbe, and B. Banner. 1989. Morphology of solid organ allografts arteriopathy. Identification of proliferating intimal cell populations. Transplant. Proc. 21:3667-3669.
15. Thyberg, J., U. Hedin, M. Sjolund, L. Palmberg, and B.A. Bottger. 1989. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 10:966-990.
16. Foegh, M.L. 1988. Eicosanoids and platelet activating factor. Mechanism in organ rejection. Transplant. Proc. 20:1260-1263.
17. Gordon, D. 1992. Growth factors and cell proliferation in human transplant arteriosclerosis. J. Heart Lung Transplant. 11:S7.
18. Allen, M., T. McDonald, T. Carlos, V. Himes, D. Fishbein, S. Aziz, and D. Gordon. 1992. Endothelial adhesion molecules in heart transplantation. J. Heart Lung Transplant. 11:S8-S13.
19. Libby, P. 1990. Inflammatory and immune mechanisms in atherogenesis. Atherosclerosis Rev. 21:79-89.
20. Hayry, P., T. Paavonen, A. Mennander, J. Ustinov, S.A. Raisanen, and K. Semstrom. 1993. Pathophysiology of allograft arteriosclerosis. Transplant. Proc. 25:2070-2071.
21. Benichou, G., and E.V. Fedoseyeva. 1996. The contribution of peptides to T cell allorecognition and allograft rejection. Intern. Rev. Immunol. 13:231-243.
22. Bradley, J.A. 1996. Indirect T cell recognition in allograft rejection. Intern. Rev. Immunol. 13:245-255.
23. Sayegh, M.H., and C.B. Carpenter. 1996. Role of indirect allorecognition in allograft rejection. Intern. Rev. Immunol. 13:221-229.
24. Colovai, A.I., E. Renna Molajoni, R. Cortesini, and N. Suciu-Foca. 1996. New approaches to specific immunomodulation in transplantation. Intern. Rev. Immunol. 13:161-172.
25. Lechler, R.I., G. Lombardi, J.R. Batchelor, N. Reinsmoen, and F.H. Bach. 1990. The molecular basis of alloreactivity. Immunol. Today. 11:83-88.
26. Lechler, R.I., T. Heaton, L. Barber, V. Ball, J.R. Batchelor, and G. Lombardi. 1992. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol. Lett. 34:63-70.
27. Mason, P.D., C.M. Robinson, and R.I. Lechler. 1996. Detection of donor-specific hyporesponsiveness following late failure of human renal allografts. Kidney Int. 50:1019-1025.
28. Quill, H., and R.H. Schwartz. 1987. Stimulation of normal inducer T cell clones with antigen presented by purified 1a molecules in planar lipid membranes: specific induction of a long-lived state of proliferative non-responsiveness. J. Immunol. 138:3704-3712.
29. Jenkins, M.K., D.M. Pardoll, J. Mizuguchi, T.M. Chused, and R.H. Schwartz. 1987. Molecular events in the induction of nonresponsive state in interleukin 2 producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA. 84:5409-5413.
30. Braun, M.Y., A. McCormack, G. Webb, and J.R. Batchelor. 1993. Evidence for clonal anergy as a mechanism for the maintenance of transplantation tolerance. Eur. J. Immunol. 23:1462-1468.
31. Liu, Z., A.I. Colovai, S. Tugulea, E.F. Reed, P.E. Fisher, D. Mancini, E.A. Rose, R. Cortesini, R.E. Michler, and N. Suciu-Foca. 1996. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J. Clin. Invest. 98:1150-1157.
32. Benichou, G., E. Fedoseyeva, P.V. Lehmann, C.A. Olson, H.M. Geysen, M. McMillan, and E.E. Sercarz. 1994. Limited T cell response to donor MHC peptides during allograft rejection. J. Immunol. 153:938-945.
33. Sercarz, E.E., and U. Krzych. 1991. The distinctive specificity of antigen-specific suppressor T cells. Immunol. Today. 12:111-118.
34. Clayton, J.P., G. Gammon, D.G. Ando, D.H. Kono, L. Hood, and E.E. Sercarz. 1989. Peplide-specific prevention of experimental allergic encephalomyelitis: neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 169:1681-1691.
35. McRae, B.L., C.L. Vanderlugt, M.C. Dal Canto, and S.D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
36. Lehmann, P.V., E.E. Sercarz, T. Forsthuber, C.M. Dayan, and G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmmune T cell repertoire. Clin. Immunol. Immunopathol. 14:203-208.
37. Liu, Z., P. Harris, A.I. Colovai, E.F. Reed, A. Maffei, and N. Suciu-Foca. 1996. Indirect recognition of donor MHC class II antigens in human transplantation. Clin. Immunol. Immunopathol. 78:228-235.
38. Zhang, J., S. Markovic-Plese, B. Lacet, J. Rays, H.L. Weiner, and D.A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973-984.
39. Harris, P.E., Z. Liu, and N. Suciu-Foca. 1992. MHC class II binding of peptides derived from HLA-DR1. J. Immunol. 148:2169-2174.
40. Yu, M., J.M. Johnson, and V.K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777-1788.
41. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
42. Vanderlugt, C.J., and S.D. Miller. 1996. Epitope spreading. Curr. Opin. Immunol. 8:831-836.
43. Mamula, M.J., and C.A. Janeway, Jr. 1993. Do B cells drive the diversification of immune responses? Immunol. Today. 14:151-154.
44. Reed, E.F., B. Hong, E. Ho, P.E. Harris, J. Weinberger, and N. Suciu-Foca. 1996. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant associated coronary artery disease. Transplantation. 61:556-572.
45. Sayegh, M.H., B. Watschinger, and C.B. Carpenter. 1994. Mechanisms of allorecognition. Recognition by in vivo primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responders presenting cells. Transplantation. 57:572-576.
46. Gallon, L., B. Watschinger, B. Murphy, E. Akalin, M.H. Sayegh, and C.B. Carpenter. 1995. The indirect pathway of allorecognition. The occurrence of self-restricted T cells recognition of allo MHC peptides early in acute renal allograph rejection and its inhibition by convention immunosuppression. Transplantation. 59:612.
47. Sayegh, M.H., and B. Carpenter. 1996. Role of indirect allorecognition in allograft rejection. Int. Rev. Immunol. 13:221-229.
48. Hosenpud, J.D., T.E. Morris, G.D. Shipley, K.A. Mauck, and C.R. Wagner. 1996. Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response. Transplantation. 61:939-948.
49. Wagner, C.R., T.E. Morris, G.D. Shipley, and J.D. Hosenpud. 1993. Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy. J. Clin. Invest. 92:1269-1277.
50. Lanzavecchia, A. 1985. Antigen-specific interactions between T and B cells. Nature. 314:537-539.
51. Casten, L.A., and S.K. Pierce. 1988. Receptor-mediated B cell antigen processing: increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell and cell clones stimulated by macrophages exposed to antigen complexed with monoclonal antibodies: a possible influence of paratope specificity on the mode of antigen processing. J. Immunol. 140:404-410.
52. Yoshikawa, M., M. Watanabe, and N. Hozumi. 1987. Analysis of proteolytic processing during specific antigen presentation. Cell. Immunol. 110: 431-435.
53. Vidard, L., K.R. Rock, and B. Benacerraf. 1992. Heterogeneity in antigen processing by different types of antigen-presenting cells. J. Immunol. 149: 1905-1911.
54. Elson, C.J., R.N. Barker, S.J. Thompson, and N.A. Williams. 1995. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol. Today. 16:71-76.
55. Tugulea, S., R. Ciubotariu, A.I. Colovai, Z. Liu, S. Itescu, L.L. Schulman, P.E. Fisher, M.A. Hardy, E.A. Rose, R.E. Michler, R. Cortesini, and N. Suciu-Foca. 1997. New strategies for early diagnosis of heart allograft rejection. Transplantation. 64:842-847.